Will we find that the $2,000 cap brings highly beneficial, highly priced drugs within reach of many Medicare beneficiaries
Eating lighter evening meals may help reduce stomach discomfort at bedtime
By helping to avoid overeating habits, including binge eating and snacking, Zepbound aids in countering unhelpful habits that can derail an individuals weight loss attempts
Stable health with no contraindications to GLP-1 Goal: sustained weight reduction inside a longevity protocol Ready to commit to 1668 weeks of treatment + lab monitoring NOT A CANDIDATE Clinical exclusions Personal/family history of medullary thyroid carcinoma or MEN-2 Currently pregnant or planning pregnancy Active pancreatitis or severe gastroparesis Your prescriber will review your full medical history at consult MAYBE DEPENDS ON LABS Conditional cases Pre-existing GI conditions Kidney function below threshold (needs additional labs) Currently on another GLP-1 or dual agonist Recent significant weight loss without medication CLINICAL NOTE Eligibility is established at consult
The regulatory status of compounded semaglutide differs from FDA-approved branded versions
Brain-Focused Pills (e.g., Qsymia, Contrave) Affect appetite and metabolism through brain pathways
